Skip to main content
. 2022 Jun 26;14(13):3137. doi: 10.3390/cancers14133137

Figure 3.

Figure 3

Kaplan-Meier estimate of survival rate in relation to cancer cachexia or sarcopenia status among 172 pancreatic cancer patients receiving chemotherapy treatment. (A,C) Overall survival curves of patients with cancer cachexia (A) or sarcopenia (C). (B,D) Progression-free survival curves of patients with cancer cachexia (B) or sarcopenia (D). p values determined using the log-rank test. CC, positive cancer cachexia status; Non-CC, negative cancer cachexia status; SC, positive sarcopenia status; Non-SC, negative sarcopenia status; mOS, median overall survival; mPFS, median progression-free survival; CI, confidence interval.